About Vyaire
Vyaire is a company based in Illinois City (United States) founded in 2016 was acquired by Apax in March 2018.. Vyaire has raised $31.53 million across 1 funding round from investors including Apax Partners. The company has 34 employees as of April 05, 2024. Vyaire has completed 4 acquisitions, including Acutronic Medical, Ciel Medical Devices and MIM Germany. Vyaire offers products and services including Vyntus BODY, Vyntus ONE, bellavista 1000e, LTV2 Series, and AVEA CVS. Vyaire operates in a competitive market with competitors including Plastiflex, Resvent, Third Pole Therapeutics, Spry Therapeutics and OmniSpirant, among others.
- Headquarter Illinois City, United States
- Employees 34 as on 05 Apr, 2024
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vyaire Medical Private Limited
- Date of Incorporation 09 Sep, 2016
- Jurisdiction Noida, Uttar Pradesh, India
-
Annual Revenue
$1.76 M (USD)37.12as on Mar 31, 2023
-
Net Profit
$107.07 K (USD)71.91as on Mar 31, 2023
-
EBITDA
$157.92 K (USD)5.74as on Mar 31, 2023
-
Total Equity Funding
$31.53 M (USD)
in 1 rounds
-
Latest Funding Round
$31.53 M (USD), Series B
Jan 29, 2019
- Investors
-
Employee Count
34
as on Apr 05, 2024
-
Investments & Acquisitions
Acutronic Medical
& 3 more
-
Acquired by
Apax
(Mar 19, 2018)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Vyaire
Vyaire offers a comprehensive portfolio of products and services, including Vyntus BODY, Vyntus ONE, bellavista 1000e, LTV2 Series, and AVEA CVS. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
System for body plethysmography in respiratory diagnostics.
Device for pulmonary and cardiopulmonary stress testing.
Ventilation support for patient respiratory needs.
Portable ventilators for long-term and transport care.
Comprehensive system for neonatal through adult ventilation.
Funding Insights of Vyaire
Vyaire has successfully raised a total of $31.53M through 1 strategic funding round. The most recent funding activity was a Series B round of $31.53 million completed in January 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 1
- Last Round Series B — $31.5M
-
First Round
First Round
(29 Jan 2019)
- Investors Count Investors Count
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jan, 2019 | Amount | Series B - Vyaire | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Vyaire
Vyaire has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Apax Partners. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Equity investments are focused on tech, services, and consumer sectors.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Vyaire
Vyaire has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Acutronic Medical, Ciel Medical Devices and MIM Germany. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Airway management products are developed for medical applications.
|
2013 | ||||
|
Specialized devices are developed to prevent ventilator-associated pneumonia in hospitals.
|
2012 | ||||
|
Non-invasive ventilation devices are developed for ENT and thoracic surgery.
|
1981 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Vyaire
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vyaire Comparisons
Competitors of Vyaire
Vyaire operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Plastiflex, Resvent, Third Pole Therapeutics, Spry Therapeutics and OmniSpirant, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Hose systems and related components are developed and manufactured.
|
|
| domain | founded_year | HQ Location |
A suite of respiratory healthcare devices is developed.
|
|
| domain | founded_year | HQ Location |
Developer of devices for cardiopulmonary therapies
|
|
| domain | founded_year | HQ Location |
Provides innovative health pillows and technologies for infection prevention and comfort.
|
|
| domain | founded_year | HQ Location |
Developing inhaled regenerative gene therapy for cystic fibrosis and COPD
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vyaire
Frequently Asked Questions about Vyaire
When was Vyaire founded?
Vyaire was founded in 2016 and raised its 1st funding round 3 years after it was founded.
Where is Vyaire located?
Vyaire is headquartered in Illinois City, United States. It is registered at Illinois City, Illinois, United States.
Who is the current CEO of Vyaire?
Gaurav Agarwal is the current CEO of Vyaire.
Is Vyaire a funded company?
Vyaire is a funded company, having raised a total of $31.53M across 1 funding round to date. The company's 1st funding round was a Series B of $31.53M, raised on Jan 29, 2019.
How many employees does Vyaire have?
As of Apr 05, 2024, the latest employee count at Vyaire is 34.
What is the annual revenue of Vyaire?
Annual revenue of Vyaire is $1.76M as on Mar 31, 2023.
What does Vyaire do?
Vyaire Medical was formed in 2016 via a joint venture between BD and Apax Partners, based in Illinois City, United States. Operations center on the medical devices sector, with emphasis on respiratory care. Devices for spirometry, pulmonary function testing, metabolic analysis, sleep diagnostics, ventilation support, anesthesia delivery, and patient monitoringincluding ECG, blood pressure, and temperature systemsare produced and supplied to healthcare providers globally.
Who are the top competitors of Vyaire?
Vyaire's top competitors include Plastiflex, Third Pole Therapeutics and Ventec Life Systems.
What products or services does Vyaire offer?
Vyaire offers Vyntus BODY, Vyntus ONE, bellavista 1000e, LTV2 Series, and AVEA CVS.
How many acquisitions has Vyaire made?
Vyaire has made 4 acquisitions, including Acutronic Medical, Ciel Medical Devices, and MIM Germany.
Who are Vyaire's investors?
Vyaire has 1 investor. Key investors include Apax Partners.